News
Phase 2 study tests an imaging probe that lights up bladder tumours
AI-assisted summary Written by WellCareChina with AI assistance and checked against the original article.
Yunnan Cancer Hospital has registered a phase 2 study, first posted on 30 September 2026, of a Trop2-targeted near-infrared (NIR-II) fluorescent probe applied to bladder specimens removed during surgery. The record notes that standard white-light cystoscopy can miss up to 30% of non-muscle-invasive bladder tumours, and that the study will compare the probe’s readings with histopathology — the laboratory examination of the tissue — in about 30 participants to estimate sensitivity and specificity.
Read the original article Opens the original source in a new tab.
Copyright and re-use
The original article is the authoritative text. This page carries our own summary and a link back; no part of the original is reproduced here.
Source tier A — trial registry record (public domain in the United States); our own summary and a link to the registry record, data as posted on 6 October 2026.